Baytacare Pharmaceutical Co., Ltd. announced unaudited earnings results for the first quarter ended March 31, 2018. For the quarter, the company reported operating loss was RMB 8,392,000 against RMB 6,707,000 a year ago. Loss before taxation was RMB 8,432,000 against RMB 6,808,000 a year ago. Loss after taxation was RMB 8,432,000 against RMB 6,808,000 a year ago. Basic loss per share of 1 cents against 0.8 cents a year ago.